Experimental

Materials and chemicals
Proteinase K (20 mg/mL), Tween 20 surfact-amps detergent solution (10%), Tris/EDTA (TE) buffer (pH 8.0), maleic anhydride activated microplates (white, 96-well), phosphate-buffered saline (PBS 10×, pH 7.4), SuperBlock blocking buffer (in PBS), SA-poly-HRP, Poly-HRP dilution buffer, SuperSignal West Pico PLUS chemiluminescent substrate, E-Gel 4% high-resolution agarose gels, a GeneRuler ultra low range DNA ladder, and Nunc adhesive plate seals were purchased from Thermo Fisher Scientific (Shanghai, China). RNase ONE ribonuclease was purchased from Promega (Fitchburg, WI, USA). miRCURY RNA isolation kit (biofluids) was purchased from Exiqon (Vedbaek, Denmark). TaqMan miRNA reverse transcription kit and TaqMan miRNA assays (hsa-miR-16, hsa-miR-25, and hsa-miR-223) were purchased from Applied Biosystems (Foster City, CA, USA). Nuclease-free water was purchased from Sangon Biotech (Shanghai, China). All oligonucleotides (HPLC grade) were synthesized and purchased from TaKaRa Biotechnology (Dalian, China).
Hydrochloric acid, sodium hydroxide, sodium citrate, sodium chloride, and EDTA (analytical grade) were purchased from Sinopharm Chemical Reagent Co., Ltd.
(Shanghai, China) and were used as received. Milli-Q ultrapure water (18.2 MΩ•cm; Millipore, Billerica, MA, USA) was used throughout the study.
The base sequences of the oligonucleotides used in this study were as follows (5′ to Jinan University. All patients provided written informed consent.
Serum-sample processing
Tween 20 solution (10%) was diluted with TE buffer (pH 8.0) to a final concentration of 1% and added to the Proteinase K solution (final concentration: 200 μg/mL) to form the serum processing solution. A frozen serum sample (−80°C) was thawed to 25°C and swirled gently five to ten times. The serum sample was mixed with the processing solution at a 1:1 ratio and incubated at 37°C for 30 min with gentle swirling. The mixture was then incubated at 60°C for 90 min with shaking at 300 rpm. The processed serum sample was then processed further or stored at −80°C
for future use.
Fixing the LO to the 96-well microplate
PBS buffer (10×; pH 7.4) was diluted with nuclease-free water to 1×, and LO was dissolved into the 1× PBS buffer to a final concentration of 1 nM. The wells of the maleic anhydride activated microplate were washed completely three times, and 100 μL of the LO solution was added to each well of the microplate. The plate was sealed tightly and incubated at 37°C for 10h to 12 h with gentle swirling. After discarding the seal and the solution, 200 μL of SuperBlock blocking buffer (in PBS) were added to the wells and incubated at 25°C for 1 h with gentle swirling. Tween 20 surfactamps detergent solution (10%) was diluted with 1× PBS buffer (pH 7.4) to a final concentration of 0.05% for use as a wash buffer. After removing the blocking buffer from the wells, the plate was washed three times with wash buffer and the microplate was used immediately or sealed and stored at 4°C for future use.
Hybridizing RNA/DNA chimera oligonucleotide (ChO) with LO
ChO was dissolved in TE buffer (pH 8.0) to a final concentration of 1 nM and 100 μL of the ChO solution was added to each well of the microplate and incubated at 37°C for 10 min with gentle swirling. After mixing completely, the plate was sealed tightly and incubated at 45°C to begin the 2 h hybridization.
Hybridizing circulating miRNAs with ChO
After removing the seal and solution, the wells of the microplate were washed three times with wash buffer, and 100 μL of the processed serum sample was added to each well and incubated at 37°C for 10 min with gentle swirling. After mixing completely, the plate was sealed tightly and incubated at 45°C to initiate overnight hybridization.
Distinguishing miRNA-ChO hybrids by SSSN
RNase ONE ribonuclease was diluted 500-fold with TE buffer (pH 8.0) to a final concentration range of 1 U/100 μL to 2 U/100 μL. After discarding the seal and solution, the wells of the microplate were washed three times with wash buffer and 100 μL of the RNase ONE ribonuclease solution was added, followed by incubation at 37°C for 10 min with gentle swirling. After mixing completely, the plate was sealed tightly and incubated at 37°C to initiate the 1 h biodegradation.
Hybridizing the SAO with ChO
Removing the seal and solution, the wells of the microplate were washed three times with wash buffer, and SAO was dissolved in TE buffer (pH 8.0) to a final concentration of 1 nM, followed by addition of 100 μL of the SAO solution to each well of the microplate and incubation at 37°C for 10 min with gentle swirling. After mixing completely, the plate was sealed tightly and incubated at 45°C to initiate the 2 h hybridization.
SA-poly-HRP binding to SAO
SA-poly-HRP was diluted 2500-fold with Poly-HRP dilution buffer. After discarding the seal and solution, the wells of the microplate were washed three times with wash buffer and 100 μL of SA-poly-HRP solution was added to each well, followed by incubation at 37°C for 30 min with gentle swirling.
Addition of the chemiluminescent substrate and signal detection
SuperSignal stable peroxide solution was mixed with SuperSignal luminol/enhancer solution at a ratio of 1:1 for use as the ECL substrate. The wells of the microplate were washed three times with wash buffer, and 100 μL of the ECL substrate was added to each well, followed by incubation at 25°C for 5 min. The plate was immediately placed in a microplate reader and the luminescence intensity was recorded using an integration time of 500 ms.
Serum miRNA isolation and qPCR
Total miRNA was extracted from clinical serum samples using the miRCURY RNA isolation kit (biofluids) according to the manufacturer's instructions (Exiqon), and TaqMan miRNA assays (Applied Biosystems) were used to quantify the expression of serum miR-16, miR-25, and miR-223. Reverse transcription was performed using the TaqMan miRNA reverse transcription kit (Applied Biosystems).
In this study, Ct values for the target miRNAs (miR-25 and miR-223) were normalized relative to that of miR-16 (endogenous control), and differential expression of the target miRNAs relative to the endogenous control was evaluated using the 2 -ΔΔCt method as previously described 1-3 .
Specificity
To determine the specificity of the direct chemiluminescence detection system (DCDS), the special RNA/DNA ChO for let-7a was utilized to hybridize the different let-7 family miRNAs (let-7a to let-7f), followed by the determination of luminescence intensity according to detection of the serum miRNA. The values of the mismatch rates for let-7b to let-7f were obtained by comparing their corresponding luminescence intensity to let-7a. All let-7 family miRNAs were artificially synthesized and detected at 1 pM concentration (in 1× PBS buffer).
Data analysis
OriginPro 8.0 software (OriginLab, Northampton, MA, USA) was used for data processing. Each sample measurement was performed in triplicate, and data were presented as the mean ± standard deviation. All tests were 2-tailed, and results with a P < 0.05 were considered statistically significant. Table S1 . Biotin modification of the SAO sequence. Name Base Sequence (5' to 3') 
Supplementary Results
SAO 1 GATTGATATTTGAATGTTTGTTTG-biotin SAO 2 GA-(biotin-T)-TGATATTTGAATGTTTGTTTG-biotin SAO 3 GA-(biotin-T)-TGATATT-(biotin-T)-GAATGTTTGTTTG-biotin SAO 4 GA-(biotin-T)-TGATATT-(biotin-T)-GAATGTT-(biotin-T)-GTTTG-biotin
